Dithiazanine

Dithiazanine

SCHEMBL29369795

CCN1/C(=C/C=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Dithiazanine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 1.00
KMT2A Q03164 7/20 1.00
NPC1 O15118 5/20 1.00
RAB9A P51151 5/20 1.00
HTT P42858 5/20 1.00
BLM P54132 4/20 1.00
MAPT P10636 4/20 1.00
ALDH1A1 P00352 3/20 1.00
THRB P10828 3/20 1.00
POLB P06746 2/20 1.00
PKM P14618 2/20 1.00
RECQL P46063 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
NPSR1 Q6W5P4 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
USP2 O75604 2/20 1.00
ALOX12 P18054 2/20 1.00
CTNNB1 P35222 2/20 1.00
LMNA P02545 2/20 1.00
KDM4E B2RXH2 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL7761426 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Iodide SCHEMBL139369 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Iodide SCHEMBL29393130 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Dithiazanine SCHEMBL22877 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Dithiazanine SCHEMBL77427 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Iodide SCHEMBL335663 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Dithiazanine SCHEMBL142280 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
Dithiazanine SCHEMBL29459605 1.00 MEN1 (1.00) MEN1KMT2ANPC1RAB9AHTT
SCHEMBL13898198 0.99 KMT2A (1.00) MEN1KMT2ANPC1RAB9AHTT
Dithiazanine SCHEMBL1567134 0.99 KMT2A (1.00) MEN1KMT2ANPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042167-A1 PHOTOINITIATIED COPOLYMER RESIN, SEPARATOR CONTAINING CROSS-LINKED STRUCTURE FOR LITHIUM SECONDARY BATTERY, AND METHOD FOR MANUFACTURING SAME 주식회사 엘지화학 2025-02-27 WO claimed
US-12173355-B2 Nano-plasmonic molecular probes and methods of use DUKE UNIVERSITY (US) 2024-12-24 US claimed
US-20240402164-A1 PLASMONIC CAGED NANOPLATFORMS AND METHODS THEREOF DUKE UNIVERSITY 2024-12-05 US claimed
US-20240401113-A1 AMPLIFICATION SYSTEMS FOR NANO-PLASMONIC MOLECULAR PROBES AND METHODS THEREOF DUKE UNIVERSITY 2024-12-05 US claimed
US-12129437-B2 Method for the dissolution of amorphous dithiazines CONOCOPHILLIPS COMPANY (US) 2024-10-29 US claimed
EP-4445150-A1 SULFUR AND AMORPHOUS DITHIAZINE MEASUREMENT CONOCOPHILLIPS COMPANY (US) 2024-10-16 EP claimed
US-12006493-B2 Nitrile solvents ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2024-06-11 US claimed
US-20240156993-A1 PLASMONICS SENSING NANOPLATFORMS FOR HUMAN STEM CELL APPLICATIONS AND METHODS THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-05-16 US claimed
EP-4225511-A1 METHOD FOR THE DISSOLUTION OF AMORPHOUS DITHIAZINES Conocophillips Company (US) 2023-08-16 EP claimed
EP-4217585-A1 NITRILE SOLVENTS Ascend Performance Materials Operations LLC (US) 2023-08-02 EP claimed
US-20220233628-A1 PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE DUKE UNIVERSITY 2022-07-28 US claimed
US-11374179-B2 Dithiazine-based hole transport material, preparing method thereof, and organic light-emitting device WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2022-06-28 US claimed
US-20220149297-A1 DITHIAZINE-BASED HOLE TRANSPORT MATERIAL, PREPARING METHOD THEREOF, AND ORGANIC LIGHT-EMITTING DEVICE WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2022-05-12 US claimed
US-11324797-B2 Plasmonics-active metal nanostar compositions and methods of use DUKE UNIVERSITY (US) 2022-05-10 US claimed
EP-3983382-A1 NOVEL NON-CODING HETEROCYCLIC AMINO ACIDS (NCHAA) AND THEIR USE AS HERBICIDES Fortephest Ltd. (IL) 2022-04-20 EP claimed
US-20220112443-A1 METHOD FOR THE DISSOLUTION OF AMORPHOUS DITHIAZINES CONOCOPHILLIPS COMPANY 2022-04-14 US claimed
WO-2022076460-A1 METHOD FOR THE DISSOLUTION OF AMORPHOUS DITHIAZINES CONOCOPHILLIPS COMPANY (US) 2022-04-14 WO claimed
US-20220098526-A1 NITRILE SOLVENTS ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2022-03-31 US claimed
WO-2022066969-A1 NITRILE SOLVENTS ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2022-03-31 WO claimed
EP-3569753-B1 METHODS FOR PRODUCING SPUNBOND NONWOVEN FABRICS MADE FROM CONTINUOUS FIBRES REIFENHAEUSER MASCH (DE) 2022-02-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220149297-A1 DITHIAZINE-BASED HOLE TRANSPORT MATERIAL, PREPARING METHOD THEREOF, AND ORGANIC LIGHT-EMITTING DEVICE FTH1, SLC40A1, TST MEN1 3460/4885KMT2A 3066/4885NPC1 831/4885
US-11374179-B2 Dithiazine-based hole transport material, preparing method thereof, and organic light-emitting device FTH1, SLC40A1, TST MEN1 3460/4885KMT2A 3066/4885NPC1 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.